SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $295,614 | +23.7% | 11,051 | +57.8% | 0.00% | 0.0% |
| Q1 2024 | $238,941 | -9.6% | 7,005 | -20.3% | 0.00% | -33.3% |
| Q2 2023 | $264,257 | -20.4% | 8,791 | -14.4% | 0.01% | -40.0% |
| Q1 2022 | $332,000 | +0.9% | 10,264 | -9.0% | 0.01% | -9.1% |
| Q4 2021 | $329,000 | +21.4% | 11,274 | +10.8% | 0.01% | 0.0% |
| Q3 2021 | $271,000 | +5.4% | 10,177 | -5.9% | 0.01% | +37.5% |
| Q2 2020 | $257,000 | -68.2% | 10,812 | -76.0% | 0.01% | -63.6% |
| Q1 2020 | $809,000 | -58.6% | 44,979 | -45.4% | 0.02% | -38.9% |
| Q4 2019 | $1,956,000 | -31.3% | 82,447 | -20.4% | 0.04% | -28.0% |
| Q3 2019 | $2,846,000 | -13.2% | 103,550 | +4.5% | 0.05% | -3.8% |
| Q2 2019 | $3,278,000 | +11.0% | 99,073 | +17.6% | 0.05% | +20.9% |
| Q1 2019 | $2,953,000 | +125.9% | 84,265 | +114.1% | 0.04% | +115.0% |
| Q4 2018 | $1,307,000 | +221.9% | 39,352 | +387.9% | 0.02% | +233.3% |
| Q3 2018 | $406,000 | +6.3% | 8,065 | +26.5% | 0.01% | 0.0% |
| Q2 2018 | $382,000 | -74.6% | 6,376 | -80.5% | 0.01% | -71.4% |
| Q1 2018 | $1,501,000 | -73.0% | 32,781 | -76.5% | 0.02% | -74.1% |
| Q4 2017 | $5,563,000 | -17.5% | 139,597 | -17.2% | 0.08% | -18.2% |
| Q3 2017 | $6,741,000 | +541.4% | 168,536 | +591.3% | 0.10% | +560.0% |
| Q2 2017 | $1,051,000 | -67.1% | 24,381 | -76.1% | 0.02% | -63.4% |
| Q1 2017 | $3,193,000 | +1157.1% | 102,001 | +719.0% | 0.04% | +1266.7% |
| Q2 2016 | $254,000 | -5.2% | 12,455 | -29.0% | 0.00% | 0.0% |
| Q1 2016 | $268,000 | -41.0% | 17,552 | -48.1% | 0.00% | -40.0% |
| Q4 2015 | $454,000 | -17.3% | 33,808 | -13.6% | 0.01% | 0.0% |
| Q3 2015 | $549,000 | -63.4% | 39,142 | -55.7% | 0.01% | -61.5% |
| Q2 2015 | $1,499,000 | +197.4% | 88,267 | +111.7% | 0.01% | +225.0% |
| Q1 2015 | $504,000 | – | 41,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |